Data from a phase 2 randomized controlled clinical trial show ensitrelvir accelerated viral clearance in patients with early symptomatic COVID-19. Plaque growth can lead to a higher risk of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback